Objective-To assess immediate and medium term results of transcatheter laser valvotomy with balloon valvoplasty in selected infants with pulmonary atresia and intact ventricular septum.
perforated using a 0*018 inch fibreoptic guidewire attached to a NdYag laser and introduced through a catheter positioned beneath the valve. After perforation the valve was dilated with progressively larger balloons. Main outcome measures-Successful laser valvotomy and balloon dilatation, complications, pulse oximetry, right ventricular outflow velocities, and need for surgical treatment. Results-Valvotomy was successful in all but one case, the failure being due to laser breakdown. After perforation the valve was dilated to 6-8 mm diameter. Prostaglandin E was withdrawn immediately in six of the eight duct dependent infants, and 28 and 49 days later in two. No patient required an aortopulmonary shunt. Two patients had repeat valvoplasty at 20 days and three months of age, respectively; one required infundibular resection and closure of the atrial septum at age four and one is awaiting similar treatment. Conclusions-Laser valvotomy with balloon valvoplasty is safe and effective treatment for selected patients with pulmonary atresia and intact ventricular septum and should be considered as first line treatment in place of surgical valvotomy.
(Heart 1997;77:225-228) Keywords: pulmonary atresia with intact ventricular septum; laser valvotomy; balloon valvoplasty Transcatheter laser valvotomy for pulmonary atresia was first reported in 1991.1 Early experience in patients with and without ventricular septal defects showed that the technique held some promise23 but it attracted negative criticism4 because of the associated risk of potentially life threatening complications such as cardiac perforation, although such risks occurred mainly in patients with ventricular septal defects or with infundibular atresia. We report our experience, over a five year period, of laser valvotomy in a selected group of patients with pulmonary atresia and intact ventricular septum.
Methods

PATIENTS
Over a four year period all patients referred with pulmonary atresia, an intact ventricular septum, a tripartite right ventricle, and no more than moderate hypoplasia of the right ventricle were treated by laser valvotomy as first line treatment, informed consent being obtained from the child's parents in each case. Their ages ranged from 0 5 to 70 days (median 4 direction of its tip were adjusted with the aid of frozen images of the pulmonary trunk in two planes. Hand injections of contrast were given immediately below the valve to ensure that it was atretic rather than very severely stenosed. A 0-018 inch (0-7 mm) fibreoptic guidewire (Trimedyne, APC Cardiovascular Ltd) was advanced to the tip of the Cobra catheter and its proximal end was connected to an Nd-YAG laser generator (Trimedyne, Cardiolase 4000). During gentle forward pressure on the guidewire, the laser was fired in continuous wave mode for periods of between five and eight seconds until the wire perforated the valve and advanced into the pulmonary trunk. Appropriate eye protection was provided for staff present in the laboratory during laser firing.
Following valve perforation either the fibreoptic wire itself or a stiffer 0-018 inch exchange wire (Flex-T, Vascular Ltd) was advanced into a distal branch pulmonary artery or into the descending aorta through the arterial duct. The Cobra catheter was then exchanged for a 3-5 or 4 mm diameter coronary angioplasty balloon catheter (Cordis Optima, Cordis Olympix, or Baxter Intrepid). After dilatation with the coronary angioplasty balloon, the valve was dilated further with a balloon of diameter up to 120% of the echocardiographically estimated pulmonary valve diameter. The patients' exposure to radiation was assessed by recording both fluoroscopy time and the number of angiograms performed. A representative case is shown in the figure.
Follow up Prostaglandin E was discontinued immediately after the procedure was completed. Pulse oximetry was monitored closely while the arterial duct was closing and prostaglandin E treatment was restarted if marked desaturation (below 50%) occurred. Repeated attempts to withdraw the drug were made until right ventricular compliance improved such that the circulation was no longer duct dependent. Right ventricular outflow velocities and oxygen saturation were measured when the duct closed. The infants were discharged from hospital after ductal closure. Further outpatient follow up included clinical examination, echocardiography, pulse oximetry when possible, and-where appropriate-repeat cardiac catheterisation with further dilatation of the pulmonary valve.
Results
The pulmonary valve was successfully perforated in all but one case, the failure being due to laser generator breakdown. This patient had a successful surgical valvotomy. In the eight successful cases between one and three laser firings of between three and five seconds at a power output of between 3 W and 5 W were required to perforate the pulmonary valve. Serial balloon dilatation after valve perfo,ration proved relatively straightforward, tracking of the balloon catheter being particularly smooth if the guidewire could be advanced across the arterial duct into the descending aorta, such that the stiffest part of the wire was positioned across the right ventricular outflow tract. No untoward effects were encountered in relation to a wire being positioned through the arterial duct. None of the patients had evidence of significant coronary artery abnormalities or right ventricular sinusoids.
Radiation exposure is summarised in table 1. Between two and six (median 3-5) digital subtraction angiograms were required, fluoroscopy time ranging from 11-3 to 98 minutes (median 30 5).
After withdrawal of prostaglandin E, two of
Laser valvotomy for pulmonary atresia is the case repeat balloon valvoplasty may be the only further treatment required.
CONCLUSIONS
Laser valvotomy followed by balloon valvoplasty is both safe and effective if patients are carefully selected for the procedure, and we recommend it as the treatment of choice.
Even patients selected for their favourable anatomy may require surgical attention in some form at a later stage. The avoidance of surgically induced scarring may have the added benefit of reducing morbidity in those patients who do prove to require surgery (for instance closure of the atrial septum or relief of infundibular pulmonary stenosis) when they are older.
